AI Analysis
AI-generated analysis. Always verify with the original filing.
Orbis Investment Management Limited reports controlling voting rights to 3,205,763 shares (4.99%) in Genmab A/S as of March 27, 2026, down from previous 5.03%.
Key Takeaways
1Orbis Investment Management Limited holds voting rights to 3,205,763 Genmab A/S shares.
2This represents 4.9895% of share capital and voting rights as of March 27, 2026.
3Previous position was 5.03%, indicating a reduction crossing below 5% threshold.
4Total voting rights in Genmab A/S: 64,250,721.
5Notification under Section 30 of Danish Capital Markets Act.
6Orbis has investment discretion over shares held by certain funds and portfolios.